Non–small cell lung cancer (NSCLC) is the leading cause of cancer‐related death in the
United States. With the implementation of lung cancer screening, the number and proportion …

Among various types of ion species, carbon ions are considered to have the most balanced,
optimal properties in terms of possessing physically and biologically effective dose …

Purpose To evaluate, in Japan Clinical Oncology Group study 0403, the safety and efficacy
of stereotactic body radiation therapy (SBRT) in patients with T1N0M0 non-small cell lung …

Background Stereotactic body radiotherapy (SBRT) has been introduced for small lung
tumors due to excellent local control and few side effects, even though there are no …

This report from the Stereotactic Radiotherapy Working Group of the German Society of
Radiation Oncology (Deutschen Gesellschaft für Radioonkologie, DEGRO) provides a …

Lung cancer is the leading cause of cancer mortality, and radiotherapy plays a key role in
both curative and palliative treatments for this disease. Recent advances include stereotactic …

Background Stereotactic body radiotherapy (SBRT) has become the standard of care for
medically inoperable patients with peripherally located, early stage non-small cell lung …

PURPOSE: To examine the rates and risk factors of radiation pneumonitis (RP) in non–small
cell lung cancer (NSCLC) patients treated with stereotactic body radiotherapy (SBRT) …

As we mark 150 years since the birth of Marie Curie, we reflect on the global advances
made in radiation oncology and the current status of radiation therapy (RT) research. Large …

Objectives The current literature on stereotactic body radiotherapy (SBRT) for
oligometastatic disease is characterized by small patient cohorts with heterogeneous …